Suppr超能文献

40-49岁女性的乳腺钼靶筛查:成本效益分析

Screening mammography in women aged 40-49 years: analysis of cost-effectiveness.

作者信息

Rosenquist C J, Lindfors K K

机构信息

Department of Radiology, University of California, Davis, School of Medicine, Sacramento 95817.

出版信息

Radiology. 1994 Jun;191(3):647-50. doi: 10.1148/radiology.191.3.8184041.

Abstract

PURPOSE

To evaluate the cost-effectiveness of screening mammography in women 40-49 years old.

MATERIALS AND METHODS

A Markov model compared two hypothetical groups; one underwent screening mammography and the other, observation without mammography. Variables tested included frequency of mammography, reduction in breast cancer mortality, and cost-effectiveness by age group. Results were expressed as marginal cost per year of life saved.

RESULTS

If the estimated mortality reduction from mammographic screening was 15% or greater, the marginal cost per year of life saved was comparable to that of other generally accepted medical procedures. Annual screening with an assumed 30% reduction in mortality had a cost-effectiveness similar to that of biennial screening with a 20% reduction. Screening mammography was less cost-effective in the 40-49-year-old age group than in women aged 50-79 years but more cost-effective than in those aged 80-84 years.

CONCLUSION

Although the parameters for screening mammography in women aged 40-49 years are not known with certainty, the results of this analysis may help establish priorities for utilization of medical resources.

摘要

目的

评估40 - 49岁女性乳腺钼靶筛查的成本效益。

材料与方法

采用马尔可夫模型比较两个假设组;一组接受乳腺钼靶筛查,另一组不进行钼靶检查仅观察。测试的变量包括钼靶检查频率、乳腺癌死亡率降低情况以及按年龄组划分的成本效益。结果以每挽救一年生命的边际成本表示。

结果

如果钼靶筛查估计的死亡率降低15%或更多,那么每挽救一年生命的边际成本与其他普遍接受的医疗程序相当。假设死亡率降低30%的年度筛查的成本效益与死亡率降低20%的两年一次筛查相似。40 - 49岁年龄组的乳腺钼靶筛查成本效益低于50 - 79岁的女性,但高于80 - 84岁的女性。

结论

尽管40 - 49岁女性乳腺钼靶筛查的参数尚不确定,但该分析结果可能有助于确定医疗资源利用的优先顺序。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验